Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ALNANASDAQ:SHC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALNAAllena Pharmaceuticals$0.07$0.06▼$1.17$37K1.1315.69 million shs96,558 shsSHCSotera Health$11.15-1.3%$11.56$9.53▼$17.08$3.16B1.881.21 million shs960,744 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALNAAllena Pharmaceuticals0.00%0.00%0.00%0.00%0.00%SHCSotera Health-1.33%+6.39%-4.62%-18.32%-1.06%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALNAAllena PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ASHCSotera Health2.3579 of 5 stars3.30.00.00.02.63.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALNAAllena Pharmaceuticals 0.00N/AN/AN/ASHCSotera Health 2.60Moderate Buy$15.2036.32% UpsideCurrent Analyst Ratings BreakdownLatest LSR, ALNA, SHC, and SHB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/23/2025SHCSotera HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.004/10/2025SHCSotera HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$16.00 ➝ $12.002/28/2025SHCSotera HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$17.00 ➝ $16.002/18/2025SHCSotera HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$18.00 ➝ $17.00(Data available from 4/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALNAAllena PharmaceuticalsN/AN/AN/AN/A$0.23 per shareN/ASHCSotera Health$1.10B2.88$1.09 per share10.27$1.57 per share7.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALNAAllena Pharmaceuticals-$48.66MN/A0.00N/AN/AN/A-287.46%-146.58%N/ASHCSotera Health$51.38M$0.1544.6015.93N/A6.31%42.27%6.02%5/1/2025 (Estimated)Latest LSR, ALNA, SHC, and SHB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025SHCSotera Health$0.12N/AN/AN/A$245.56 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALNAAllena PharmaceuticalsN/AN/AN/AN/AN/ASHCSotera HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALNAAllena PharmaceuticalsN/A1.581.58SHCSotera Health4.912.882.61Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALNAAllena Pharmaceuticals7.33%SHCSotera Health91.03%Insider OwnershipCompanyInsider OwnershipALNAAllena Pharmaceuticals3.70%SHCSotera Health55.12%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALNAAllena Pharmaceuticals35122.08 million117.57 millionNot OptionableSHCSotera Health3,000283.86 million127.12 millionOptionableLSR, ALNA, SHC, and SHB HeadlinesRecent News About These CompaniesSotera Health (SHC) to Release Earnings on ThursdayApril 26 at 1:55 AM | marketbeat.comSotera Health (NASDAQ:SHC) Price Target Lowered to $13.00 at Piper SandlerApril 25 at 3:25 AM | americanbankingnews.com365,386 Shares in Sotera Health (NASDAQ:SHC) Purchased by Khrom Capital Management LLCApril 24 at 7:37 AM | marketbeat.comSotera Health price target lowered to $13 from $15 at Piper SandlerApril 24 at 4:10 AM | markets.businessinsider.comSotera Health (SHC) Receives a Hold from Piper SandlerApril 24 at 4:10 AM | markets.businessinsider.comSotera Health (SHC) Price Target Revised to $13 as Earnings Approach | BDX Stock NewsApril 23 at 1:48 PM | gurufocus.comSotera Health (NASDAQ:SHC) Shares Purchased by Voss Capital LPApril 23 at 6:21 AM | marketbeat.comCerity Partners LLC Sells 36,219 Shares of Sotera Health (NASDAQ:SHC)April 21, 2025 | marketbeat.comSotera Health Announces First-Quarter 2025 Earnings Release DateApril 17, 2025 | gurufocus.comSotera Health Announces First-Quarter 2025 Earnings Release DateApril 17, 2025 | gurufocus.comSotera Health Company to Release Q1 2025 Financial Results on May 1, 2025April 17, 2025 | quiverquant.comSotera Health Announces First-Quarter 2025 Earnings Release Date | SHC Stock NewsApril 17, 2025 | gurufocus.comSotera Health Announces First-Quarter 2025 Earnings Release DateApril 17, 2025 | globenewswire.comWalleye Capital LLC Has $10.60 Million Holdings in Sotera Health (NASDAQ:SHC)April 17, 2025 | marketbeat.comGeode Capital Management LLC Raises Stake in Sotera Health (NASDAQ:SHC)April 17, 2025 | marketbeat.comIs the Options Market Predicting a Spike in Sotera Health (SHC) Stock?April 14, 2025 | zacks.comSotera Health Company (SHC): Buy, Sell, or Hold Post Q4 Earnings?April 14, 2025 | msn.comSotera Health (NASDAQ:SHC) Hits New 12-Month Low - Should You Sell?April 11, 2025 | marketbeat.comSotera Health price target lowered to $12 from $16 at BarclaysApril 11, 2025 | markets.businessinsider.comBarclays Adjusts Price Target for Sotera Health (SHC) Shares Amid Earnings Preview | SHC Stock NewsApril 10, 2025 | gurufocus.comNorges Bank Invests $12.76 Million in Sotera Health (NASDAQ:SHC)April 9, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLSR, ALNA, SHC, and SHB Company DescriptionsAllena Pharmaceuticals NASDAQ:ALNAAllena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.Sotera Health NASDAQ:SHC$11.15 -0.15 (-1.33%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$11.16 +0.00 (+0.04%) As of 04/25/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/21 - 04/25 Bears Can Reap Big Benefits With These 3 Short ETF Bets If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Markets Think Robinhood Earnings Could Send the Stock Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
